{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-039726","form_type":"8-K","ticker":"TIL","cik":"0001789769","company_name":"Instil Bio, Inc.","filed_at":"2024-09-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.533937+00:00","generated_at":"2026-05-31T06:06:04.284906+00:00","sec_items":["2.05"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Instil Bio to close remaining UK operations, cut workforce, incur up to $5.5M in restructuring costs","bullets":["Board approved restructuring plan to close Manchester, UK operations and eliminate remaining UK workforce.","Estimated aggregate restructuring costs up to $5.5M, including asset impairment ($2.2M), severance ($2.0M), and contract termination ($1.3M).","Workforce reduction expected to be substantially complete by end of 2024.","Charges are subject to assumptions; additional costs may arise not currently contemplated."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-039726","json":"https://secwatch.observer/filing/0001628280-24-039726.json","markdown":"https://secwatch.observer/filing/0001628280-24-039726.md","text":"https://secwatch.observer/filing/0001628280-24-039726.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1789769/000162828024039726/0001628280-24-039726-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1789769/000162828024039726/til-20240901.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:06:04.284906+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}